BMJ1d
The history of osteoarthritis-osteoarthrosis
ProfessorDr J Dequeker, Department of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium; jan.dequeker{at}med.kuleuven.be The history of osteoarthritis-osteoarthrosis ...
BMJ2d
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
2 Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Austria Background and objectives Instruments for measuring disease activity in psoriatic arthritis (PsA) are not ...
BMJ4d
Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system
Eamonn S Molloy, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; molloye{at}ccf.org Objective ...
BMJ4d
Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K + CD8 T cell activation in lupus kidney
2 Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China 3 University of Chinese Academy of Sciences, Beijing, ...
BMJ4d
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study
Correspondence to Dr Lindi Jiang, Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; zsh-rheum{at}hotmail.com Antineutrophil cytoplasm antibody-associated ...
BMJ4d
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
Background Studies examining the relationship between serological status (rheumatoid factor and/or anticitrullinated antibody) and rituximab treatment outcome in rheumatoid arthritis (RA) have been ...
BMJ5d
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs
The increasing prevalence of autoimmune and immune-mediated diseases (AIMDs) underscores the need to understand environmental ...
BMJ6d
Studies with pain rating scales.
Good correlation has been shown between pain scores derived from 4 different rating scales. The correlation was maintained when presentation of the scales was separated by a series of questions and by ...
BMJ7d
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
4 Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte, Universidade de Lisboa, and Centro Académico deMedicina de Lisboa, Lisbon, Portugal 5 Oxford NIHR Biomedical Research Centre ...
BMJ7d
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...
BMJ7d
2023 EULAR classification criteria for hand osteoarthritis
Objectives The objective of this study is to develop classification criteria for overall hand osteoarthritis (OA), interphalangeal OA and thumb base OA based on self-reported data and radiographic ...
BMJ8d
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial
1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...